Free Trial

Finch Therapeutics Group (FNCH) SEC Filings & 10K Form

$1.80
-0.18 (-9.09%)
(As of 05/24/2024 ET)

Recent Finch Therapeutics Group SEC Filings

DateFilerForm TypeView
05/24/2024
7:00 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:05 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
3:45 PM
Finch Therapeutics Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:57 PM
Finch Therapeutics Group (Filer)
Form 10-K/A
04/03/2024
6:30 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:15 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
4:20 PM
Finch Therapeutics Group (Subject)
Ugwumba Chidozie (Filed by)
Form SC 13G
11/27/2023
3:54 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:37 PM
Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:30 PM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
5:30 AM
Finch Therapeutics Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2023
5:31 AM
Finch Therapeutics Group (Filer)
Form 10-Q/A
08/10/2023
5:31 AM
Finch Therapeutics Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/28/2023
3:31 PM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:30 PM
Blischak Matthew P. (Reporting)
Finch Therapeutics Group (Issuer)
Form 4/A
06/23/2023
6:30 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2023
2:05 PM
Finch Therapeutics Group (Issuer)
Shumway Chris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FNCH) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners